Pfizer Lipitor Patent Claiming Crystalline Atorvastatin Is Valid, PTO Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The Public Patent Foundation nevertheless asserts victory, saying Pfizer was forced to narrow the claims for the '156 patent.